Research Paper Volume 15, Issue 20 pp 11217—11226
Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia
Figure 1. Changes in prognosis, signaling pathways, and immune function between high and low CS-score groups. (A) Differences in patients’ overall survival (OS) in the high and low CS-score groups, log-rank test. (B, C) Gene set enrichment analysis revealed the signaling pathways that were significantly enriched differently between high and low CS-score groups. (B) High CS-score group; (C) Low CS-score group. (D) Differences in Infiltration levels of 22 immune cells between high and low CS-score groups. (E) Differences in expression of immune checkpoints between high and low CS-score groups. *P < 0.05, **P < 0.01, ***P < 0.001.